JANX
Janux Therapeutics (JANX)
$18
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$14.65
Daily low
$13.88
Price at open
$14.44
52 Week High
$35.34
52 Week Low
$12.12
Market cap
884.5M
Dividend yield
0.00%
Volume
865,870
Avg. volume
974,708
P/E ratio
-7.93
Janux Therapeutics News
Details
Daily high
$14.65
Daily low
$13.88
Price at open
$14.44
52 Week High
$35.34
52 Week Low
$12.12
Market cap
884.5M
Dividend yield
0.00%
Volume
865,870
Avg. volume
974,708
P/E ratio
-7.93